Skip to content

Cerus CERS Return on equity

Return on equity at other companies

CorMedix logo
CorMedixCRMD
65.6%
Haemonetics logo
HaemoneticsHAE
19.3%+5.2pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.5%+1.3pp
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-17.1%-26.1pp
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
-49.9%-70.8pp
ADMA Biologics logo
ADMA BiologicsADMA
43.3%-35.2pp

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Calculated from Cerus’s reported figures.

Based on trailing twelve months.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's return on equity?
Cerus (CERS) reported return on equity of -15.5% in Q1 2026.
How has Cerus's return on equity changed year-over-year?
Cerus's return on equity increased by 57.0% year-over-year, from -36.1% to -15.5%.
What is the long-term trend for Cerus's return on equity?
Over 5 years (2020 to 2025), Cerus's return on equity has grown at a -19.0% compound annual growth rate (CAGR), from -74.4% to -26%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.